Insufficient scRNA-seq data for expression of OXER1 at single-cell level.
Insufficient scRNA-seq data for expression of OXER1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2253.13 | 226 / 226 | 99% | 34.39 | 402 / 406 |
kidney | 100% | 557.70 | 89 / 89 | 89% | 12.21 | 800 / 901 |
pancreas | 100% | 316.43 | 328 / 328 | 84% | 4.27 | 150 / 178 |
uterus | 99% | 392.75 | 168 / 170 | 70% | 6.73 | 322 / 459 |
intestine | 95% | 320.89 | 918 / 966 | 73% | 6.20 | 383 / 527 |
prostate | 100% | 576.76 | 245 / 245 | 66% | 3.55 | 332 / 502 |
stomach | 95% | 144.79 | 341 / 359 | 71% | 5.97 | 202 / 286 |
bladder | 100% | 515.76 | 21 / 21 | 58% | 3.57 | 291 / 504 |
lung | 97% | 160.15 | 559 / 578 | 56% | 3.23 | 652 / 1155 |
esophagus | 95% | 172.08 | 1378 / 1445 | 56% | 4.07 | 102 / 183 |
thymus | 98% | 198.49 | 640 / 653 | 50% | 3.56 | 300 / 605 |
breast | 91% | 166.34 | 417 / 459 | 37% | 2.23 | 419 / 1118 |
ovary | 100% | 703.38 | 180 / 180 | 26% | 1.02 | 112 / 430 |
adrenal gland | 93% | 137.17 | 240 / 258 | 16% | 1.01 | 36 / 230 |
skin | 72% | 173.64 | 1297 / 1809 | 30% | 1.85 | 141 / 472 |
spleen | 100% | 392.89 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.41 | 1 / 1 |
peripheral blood | 100% | 1045.77 | 926 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 217.38 | 1285 / 1335 | 0% | 0 | 0 / 0 |
adipose | 91% | 160.02 | 1100 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 9.18 | 26 / 29 |
brain | 49% | 40.43 | 1299 / 2642 | 36% | 1.61 | 255 / 705 |
heart | 74% | 105.06 | 635 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 71% | 5.79 | 32 / 45 |
eye | 0% | 0 | 0 / 0 | 39% | 2.77 | 31 / 80 |
muscle | 20% | 16.28 | 160 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0050648 | Molecular function | 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0050647 | Molecular function | 5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding |
GO_0050646 | Molecular function | 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding |
Gene name | OXER1 |
Protein name | Alternative protein OXER1 Oxoeicosanoid receptor 1 (5-oxo-ETE G-protein coupled receptor) (G-protein coupled receptor 170) (G-protein coupled receptor R527) (G-protein coupled receptor TG1019) |
Synonyms | TG1019 GPR170 |
Description | FUNCTION: Receptor for eicosanoids and polyunsaturated fatty acids such as 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-OXO-ETE), 5(S)-hydroperoxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5(S)-HPETE) and arachidonic acid. Seems to be coupled to the G(i)/G(o), families of heteromeric G proteins. . |
Accessions | Q8TDS5 ENST00000378661.4 L8E891 |